Immunocellular Therapeutics, Ltd. (IMUC) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Join SI Premium – FREE
Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q2 EPS of $0.04, $0.10 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Immunocellular Therapeutics, Ltd. (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
